How is Anavar dosed?
| Source | Strength or dose | Schedule |
|---|---|---|
| Label, tablets | 2.5 mg or 10 mg1 | Oral1 |
| Label, adults | 2.5 mg to 20 mg a day1 | 2 to 4 divided doses1 |
| Label, older adults | 5 mg1 | Twice a day1 |
| Label, children | Up to 0.1 mg per kg a day1 | Total daily dose1 |
| Logged in Milligram (share of people) | 20 mg (20%), 25 mg (20%), 50 mg (15%), 10 mg (14%) a dose14 | n/a |
The Oxandrin label gives 2.5 mg to 20 mg a day in 2 to 4 divided doses, usually as a course of 2 to 4 weeks, and 5 mg twice a day for older adults.1
Tablet strengths and daily schedules
The table is set at the top of the page
That label was issued in January 2006 for adjunctive use and says the response to anabolic steroids varies; FDA has since determined that Oxandrin was withdrawn from sale for reasons of safety or effectiveness.12 For older adults it gives greater sensitivity to fluid retention and transaminase rises as the reason for a lower dose.1
A tablet needs no syringe mark, and no U-100 mark is given for oxandrolone in the sources reviewed.
Doses in trials, and women
No trial below was designed to test doses for physique or sport in healthy young people.
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Grunfeld 20065 | Placebo or 20, 40 or 80 mg daily, then open-label 20 mg | Two hundred sixty-two HIV-infected men with 10% to 20% weight loss or a body mass index of 20 or less | 12 weeks double-blind, then 12 weeks open-label |
| Schroeder 20046 | 20 mg a day or placebo | Thirty-two healthy men aged 60 to 87 (20 on oxandrolone, 12 on placebo) | 12 weeks |
| Mavros 20157 | 10 mg a day or placebo, with high-intensity resistance training | Twenty-nine sedentary older women | 12 weeks |
| Bauman 20138 | 20 mg a day or placebo | 212 inpatients with spinal cord injury and stage III or IV pressure ulcers (108 on oxandrolone, 104 on placebo) | Until the ulcer healed or 24 weeks |
| Sheffield-Moore 19999 | 15 mg a day by mouth | Six healthy men aged about 22 | 5 days |
| Kahn 200610 | 10 mg twice daily | 14 healthy people | 14 days |
The label gives women no separate dose.1 It says women are to be observed for signs of virilization (deepening of the voice, hirsutism, acne, clitoromegaly) and lists pregnancy as a contraindication.1 Of the trials above only Mavros enrolled women, and no trial in menopausal women appears in the sources reviewed.7
Injection, mixing and buccal use
The label's How Supplied section lists only 2.5 mg and 10 mg tablets, and the sources reviewed give no mixing or reconstitution step.1 No label, regulator record or trial describes an injectable oxandrolone in the sources reviewed. The nearest non-oral form in the ClinicalTrials.gov listing is NCT06974526, a recruiting phase 2 trial of a subdermal bioabsorbable oxandrolone pellet after ACL reconstruction, with a listed enrollment of 96.11
The one published preparation, in a study by Linakis, Rower and colleagues, had the Primary Children's Hospital compounding pharmacy grind four 2.5 mg tablets (10 mg in all) and suspend them in MCT oil to 10 mL, or 1 mg/mL.12 In neonates after surgery for complex congenital heart defects it was given to the buccal mucosa at 0.1 mg per kg a day, once daily, for 30 days, and a further 5-patient cohort got 0.2 mg per kg a day given twice daily.12 In a crossover in 6 healthy adult men given 0.1 mg per kg as a tablet or as the oil held at the cheek for 5 minutes, the authors report a mean buccal bioavailability of 62.5% for the oil, and say both neonatal and adult pharmacokinetics were variable.12 No sublingual study appears in the sources reviewed.
What the sources say on storage
The Oxandrin label as published on DailyMed has no storage or temperature statement.1 In the sources reviewed, the only storage data are for the compounded MCT oil: it was kept in an amber bottle at room temperature, about 20°C, and was stable for at least 1 month at ambient conditions in glass or plastic amber vials protected from light.12
Frequently asked questions
What do Anavar tablets look like?
The Oxandrin label describes both strengths as white tablets, the 2.5 mg oval and scored and the 10 mg capsule shaped.1
Is Anavar banned in sport?
The World Anti-Doping Agency's Prohibited List names oxandrolone among the anabolic androgenic steroids in class S1.1, prohibited at all times.13
Is Anavar a controlled substance?
The label says oxandrolone is a US Schedule III controlled substance under the Anabolic Steroids Control Act of 1990.1
More on anabolic steroids
How the logged figures are counted
Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.
References
- Savient Pharmaceuticals via DailyMed (US FDA label, issued January 2006). Oxandrin (oxandrolone tablets, USP) CIII, prescribing information. 2006. dailymed.nlm.nih.gov
- US Food and Drug Administration, Federal Register 88 FR 62799. Determination That Oxandrin (Oxandrolone) Tablets, 2.5 mg and 10 mg, Were Withdrawn From Sale for Reasons of Safety or Effectiveness. 2023. federalregister.gov
- US Food and Drug Administration, Federal Register. Determination That Oxandrin (Oxandrolone) Tablets Were Withdrawn From Sale for Reasons of Safety or Effectiveness; Correction. 2026. federalregister.gov
- US National Library of Medicine, DailyMed. DailyMed label search by drug name oxandrolone (raw API response). 2026. dailymed.nlm.nih.gov
- J Acquir Immune Defic Syndr (PubMed abstract). Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. 2006. pubmed.ncbi.nlm.nih.gov
- J Appl Physiol (PubMed abstract). Treatment with oxandrolone and the durability of effects in older men. 2004. pubmed.ncbi.nlm.nih.gov
- Med Sci Sports Exerc (PubMed abstract). Oxandrolone augmentation of resistance training in older women: a randomized trial. 2015. pubmed.ncbi.nlm.nih.gov
- Ann Intern Med (PubMed abstract). The effect of oxandrolone on the healing of chronic pressure ulcers in persons with spinal cord injury: a randomized trial. 2013. pubmed.ncbi.nlm.nih.gov
- J Clin Endocrinol Metab (PubMed abstract). Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. 1999. pubmed.ncbi.nlm.nih.gov
- Am J Hematol (PubMed abstract). Effects of oxandrolone, an anabolic steroid, on hemostasis. 2006. pubmed.ncbi.nlm.nih.gov
- US National Library of Medicine, ClinicalTrials.gov. ClinicalTrials.gov registry search for the intervention oxandrolone (listing rendered from the API response). 2026. clinicaltrials.gov
- J Pediatr Pharmacol Ther (full text, PubMed Central). Stability of oxandrolone in medium-chain triglyceride oil and pharmacokinetics following buccal administration of the extemporaneous formulation in neonates and adults. 2020. pmc.ncbi.nlm.nih.gov
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. 2026. wada-ama.org
- Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted